Updated COVID-19 Vaccine Being Produced By Novavax Likely To Work Against Fast-Growing Variants In US, Company R&D President Says

Reuters (6/5, Erman) reports Novavax R&D President Filip Dubovsky, MD, MPH, on Monday “said an updated COVID-19 vaccine the company is already producing is likely to be protective against other fast-growing coronavirus variants circulating in the U.S.” No...